Clinical Trial Update: MSB0010445 and Stereotactic Body Radiation Therapy in Advanced Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating MSB0010445 in combination with stereotactic body radiation therapy for advanced melanoma was terminated, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• MSB0010445
• Stereotactic Body Radiation Therapy (SBRT)

Snippet

Sponsor: EMD Serono | Conditions: Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2016-10-31